• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

学术医学中心在推进监管科学中的作用。

The role of academic medical centers in advancing regulatory science.

机构信息

Virginia Center for Translational and Regulatory Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

出版信息

Clin Pharmacol Ther. 2014 May;95(5):471-3. doi: 10.1038/clpt.2014.33.

DOI:10.1038/clpt.2014.33
PMID:24747233
Abstract

The US Food and Drug Administration (FDA) has oversight of an increasingly complex array of therapeutic and scientific advances, as well as an expanded mission that now includes enabling innovation. This complex mission necessitates access to and understanding of relevant scientific expertise in what is commonly called “regulatory science.” Academic medical centers have much of this relevant expertise, and there is an increasing need and opportunity for the FDA to engage with them to shape the regulatory science agenda.

摘要

美国食品和药物管理局(FDA)负责监管日益复杂的治疗和科学进步,以及扩大的任务,现在包括促进创新。这项复杂的任务需要获得并理解通常被称为“监管科学”的相关科学专业知识。学术医疗中心拥有大量相关专业知识,FDA 越来越需要并有机遇与它们合作,制定监管科学议程。

相似文献

1
The role of academic medical centers in advancing regulatory science.学术医学中心在推进监管科学中的作用。
Clin Pharmacol Ther. 2014 May;95(5):471-3. doi: 10.1038/clpt.2014.33.
2
[Role of academic medicine for innovations in development of drugs and biomedicine technology].[学术医学在药物与生物医学技术研发创新中的作用]
Dtsch Med Wochenschr. 2013 Oct;138(40):1993-4. doi: 10.1055/s-0033-1349535. Epub 2013 Sep 24.
3
Translational research: moving discovery to practice.转化研究:将发现转化为实践。
Clin Pharmacol Ther. 2007 Jan;81(1):126-8. doi: 10.1038/sj.clpt.6100029.
4
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.推进主动监测研究:观察性医疗结局合作研究的原理和设计。
Ann Intern Med. 2010 Nov 2;153(9):600-6. doi: 10.7326/0003-4819-153-9-201011020-00010.
5
The history and contemporary challenges of the US Food and Drug Administration.美国食品药品监督管理局的历史与当代挑战
Clin Ther. 2007 Jan;29(1):1-16. doi: 10.1016/j.clinthera.2007.01.006.
6
Collaborating with industry--choices for the academic medical center.与产业界合作——学术医疗中心的选择
N Engl J Med. 2002 Oct 24;347(17):1371-5. doi: 10.1056/NEJMsb021319.
7
Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.食品和药物管理局对新放射性药物的测试和批准要求。
Semin Nucl Med. 2010 Sep;40(5):364-84. doi: 10.1053/j.semnuclmed.2010.05.002.
8
Is it possible for FDA regulatory scientists and industry scientists to work together?美国食品和药物管理局的监管科学家和工业界科学家是否有可能合作?
Clin Pharmacol Ther. 2012 Mar;91(3):390-2. doi: 10.1038/clpt.2011.304.
9
Tapping Into Valuable Expertise From Private Practitioners and Academicians: Casting a Wider Net.挖掘私人执业医生和院士的宝贵专业知识:扩大范围。
JAMA Ophthalmol. 2015 Aug;133(8):865-6. doi: 10.1001/jamaophthalmol.2015.1310.
10
Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry.学术界与产业界合作开展的银屑病转化研究与药物研发
J Invest Dermatol. 2020 Mar;140(3):524-526. doi: 10.1016/j.jid.2020.01.002. Epub 2020 Jan 13.

引用本文的文献

1
Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe.将药物研发学术成果转化为临床开发:对欧洲利益相关者对监管支持和要求的认识进行调查。
Clin Pharmacol Ther. 2023 Feb;113(2):349-359. doi: 10.1002/cpt.2789. Epub 2022 Nov 21.
2
Advancing a Vision for Regulatory Science Training.推进监管科学培训的愿景。
Clin Transl Sci. 2015 Oct;8(5):615-8. doi: 10.1111/cts.12298. Epub 2015 Jun 17.